John C. LaRosa

18.3k citations

120 papers · 11.4k indexed · 6 hit papers · h-index 39

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 0.1%
- Lipoproteins and Cardiovascular Health

Papers in

Endocrinology, Diabetes and Metabolism 58
- Diabetes, Cardiovascular Risks, and Lipoproteins 47
- Menopause: Health Impacts and Treatments 8
Surgery 76
- Lipoproteins and Cardiovascular Health 74

Co-authors: Scott M. Grundy John J.P. Kastelein Philip J. Barter Antonio M. Gotto Jean‐Charles Fruchart Suma Vupputuri Jiang He James Shepherd
Journals: The American Journal of Cardiology (15 papers)Circulation (12 papers)Journal of the American College of Cardiology (7 papers)The American Journal of Medicine (6 papers)Current Atherosclerosis Reports (4 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

John C. LaRosa

114 papers receiving 10.6k citations

Hit Papers

6 papers align trajectories log scale

Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins 2012 · 577 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 JAMA
2007 New England Journal of Medicine
2005 New England Journal of Medicine
1999 JAMA
1990 Circulation
1970 Biochemical and Biophysical Research Communications

Peers

Countries citing papers authored by John C. LaRosa

Since Specialization

Citations

This map shows the geographic impact of John C. LaRosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. LaRosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. LaRosa more than expected).

Fields of papers citing papers by John C. LaRosa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. LaRosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. LaRosa. The network helps show where John C. LaRosa may publish in the future.

Co-authors

The 25 scholars most cited alongside John C. LaRosa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John C. LaRosa Line = papers co-authored together John C. LaRosa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Statins: Do They Have Beneficial Effects Over and Above Their Actions on Lipids? James A. Reiffel, Antonio M. Gotto, John C. LaRosa	2020	0
2	RELATIONSHIP BETWEEN SOLUBLE F11 RECEPTOR, TOTAL NITRIC OXIDE LEVELS, AND VASCULAR FUNCTION IN AFRICAN AMERICANS WITH TYPE II DIABETES Journal of the American College of Cardiology ·Anne Birgitte Nordal, A. L. Gilman, Fasika Tedla, Xi-Heng Chen, 悠介荒井, Payel Bhattacharjee, Carl Rosenberg, Paul Dreizen, John C. LaRosa, Louis Salciccioli, Manuel Lasala-Gausa, Mary Ann Banerji, Clinton D. Brown, Moro O. Salifu, Jason Lazar, Ahmed Bakillah	2019	1
3	Safety and Effect of Very Low Levels of Low-Density Lipoprotein Cholesterol on Cardiovascular Events The American Journal of Cardiology ·John C. LaRosa, Terje R. Pedersen, Ransi Somaratne, Scott M. Wasserman	2013	29
4	Lipid-Modifying Therapies and Risk of Pancreatitis JAMA ·David Preiss, Matti J. Tikkanen, Paul Welsh, Ian Ford, Laura Lovato, Marshall B. Elam, John C. LaRosa, David A. DeMicco, Helen M. Colhoun, Ilan Goldenberg, Michael J. Murphy, Thomas M. MacDonald, Terje R. Pedersen, Anthony Keech, Paul M. Ridker, John Kjekshus, Naveed Sattar, John J.V. McMurray	2012	111
5	THE TRP719ARG VARIANT OF KIF6 AND CARDIOVASCULAR OUTCOMES IN STATIN-TREATED, CORONARY STABLE PATIENTS OF THE TNT AND IDEAL PROSPECTIVE STUDIES Journal of the American College of Cardiology ·Benoît Arsenault, S. Matthijs Boekholdt, G. Kees Hovingh, Craig Hyde, David A. DeMicco, Aurobindo Chatterjee, Philip J. Barter, Prakash Deedwania, David D. Waters, John C. LaRosa, Terje R. Pedersen, J. Kastelein	2011	1
6	The Editor's Roundtable: Closing the Clinical Practice Gap—Using Evidence-Based Treatments for Managing Lipids The American Journal of Cardiology ·William C. Roberts, Antonio M. Gotto, John R. Guyton, John C. LaRosa, Juan Dionisio Osores	2011	0
7	VITAMIN D LEVELS ARE NOT RELATED TO MYALGIAS IN STATIN-TREATED PATIENTS WITH STABLE CORONARY DISEASE Journal of the American College of Cardiology ·Vera Bittner, Nanette K. Wenger, David D. Waters, David A. DeMicco, Michael Messig, John C. LaRosa	2010	8
8	VITAMIN D LEVELS DO NOT PREDICT CARDIOVASCULAR EVENTS IN STATIN-TREATED PATIENTS WITH STABLE CORONARY DISEASE Journal of the American College of Cardiology ·Vera Bittner, Nanette K. Wenger, David D. Waters, David A. DeMicco, Michael Messig, John C. LaRosa	2010	4
9	Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial) The American Journal of Cardiology ·John C. LaRosa, Prakash Deedwania, James Shepherd, Nanette K. Wenger, Heiner Greten, David A. DeMicco, Andrei Breazna	2009	46
10	Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery Journal of the American College of Cardiology ·Sanjiv J. Shah, David D. Waters, Philip J. Barter, John J.P. Kastelein, James Shepherd, Nanette K. Wenger, David A. DeMicco, Andrei Breazna, John C. LaRosa	2008	70
11	The Benefits of Intensive Lipid Lowering in Patients With Stable Coronary Heart Disease With Normal or High Systolic Blood Pressure: An Analysis of the Treating to New Targets (TNT) Study Journal of Clinical Hypertension ·John B. Kostis, Andrei Breazna, Prakash Deedwania, John C. LaRosa	2008	12
12	Abstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) Trials Circulation ·John J.P. Kastelein, Ingar Holme, Philip J. Barter, Anders Olsson, Nilo B. Cater, David A. DeMicco, Michael Gaffney, Michael Szarek, John C. LaRosa, Terje R. Pedersen	2006	2
13	Poor compliance: The hidden risk factor Current Atherosclerosis Reports ·John C. LaRosa	2000	13
14	Cholesterol management in women and the elderly Journal of Internal Medicine ·John C. LaRosa	1997	3
15	Should High Lipid Levels in Very Old Patients Be Lowered? Drugs & Aging ·John C. LaRosa	1995	4
16	Long-term treatment of hypercholesterolemia with dietary fiber The American Journal of Medicine ·Donald B. Hunninghake, Valery T. Miller, John C. LaRosa, Bruce Kinosian, Terry A. Jacobson, Guo Ye Xia, Wm. James Howard, David A. Edelman, Seema Gupta	1994	42
17	Cholesterol lowering, low cholesterol, and mortality The American Journal of Cardiology ·John C. LaRosa	1993	26
18	Contraception and dyslipidemia American Journal of Obstetrics and Gynecology ·Naoki Fukumori, John C. LaRosa, Moo-Sik Cho	1993	18
19	Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia Journal of the American College of Cardiology ·Víctor Bonet-Arbolí, Valery T. Miller, Diane B. Stoy, Richard A. Muesing, 安健锋, John C. LaRosa	1990	2
20	The association of corneal arcus with coronary heart disease and cardiovascular disease mortality in the Lipid Research Clinics Mortality Follow-up Study. American Journal of Public Health ·Lloyd E. Chambless, Flávio Danni Fuchs, Shai Linn, Stephen B. Kritchevsky, John C. LaRosa, P Segal, Basil M. Rifkind	1990	32

About John C. LaRosa

John C. LaRosa is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Family Practice and Economics and Econometrics, having authored 120 papers that have together received 11.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (74 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (47 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers), Cancer, Lipids, and Metabolism (21 papers), Estrogen and related hormone effects (9 papers), Pharmaceutical Economics and Policy (8 papers), Menopause: Health Impacts and Treatments (8 papers) and Blood Pressure and Hypertension Studies (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.7k citations), Surgery (6.8k citations), Cardiology and Cardiovascular Medicine (3.4k citations), Cancer Research (1.5k citations) and Economics and Econometrics (2.0k citations). John C. LaRosa has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Scott M. Grundy, John J.P. Kastelein, Philip J. Barter, Antonio M. Gotto, Jean‐Charles Fruchart, Suma Vupputuri, Jiang He, James Shepherd, David D. Waters and Heiner Greten. Their work appears in journals such as The American Journal of Cardiology, Circulation, Journal of the American College of Cardiology, The American Journal of Medicine and Current Atherosclerosis Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact